BIOMAT Database Logo BIOMAT Database Logo

The high-risk benign tumor: evidence from the two-stage skin cancer model and relevance for human cancer. 2007

Adam Glick, and Andrew Ryscavage, and Rolando Perez-Lorenzo, and Henry Hennings, and Stuart Yuspa, and Nadine Darwiche
Center for Molecular Toxicology and Carcinogenesis, The Pennsylvania State University, University Park, Pennsylvania 16801, USA.

Benign tumors that form following chemical initiation and promotion in the mouse skin can be grouped into two classes. The majority of papillomas do not progress to squamous cell carcinoma (SCC), and these are designated as low-risk or terminally benign papillomas. In contrast, a much smaller group forms the true precursor to the SCC, and these have a significantly higher frequency and rate of malignant conversion than the bulk of low-risk papillomas. In standard two-stage carcinogenesis studies both tumor types are present, but grossly indistinguishable. Here we describe properties and potential origins of high-risk papillomas and discuss the relevance of this model for certain human cancers with defined premalignant states.

UI MeSH Term Description Entries
D010212 Papilloma A circumscribed benign epithelial tumor projecting from the surrounding surface; more precisely, a benign epithelial neoplasm consisting of villous or arborescent outgrowths of fibrovascular stroma covered by neoplastic cells. (Stedman, 25th ed) Papilloma, Squamous Cell,Papillomatosis,Papillomas,Papillomas, Squamous Cell,Papillomatoses,Squamous Cell Papilloma,Squamous Cell Papillomas
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm

Related Publications

Adam Glick, and Andrew Ryscavage, and Rolando Perez-Lorenzo, and Henry Hennings, and Stuart Yuspa, and Nadine Darwiche
Cav1 inhibits benign skin tumor development in a two-stage carcinogenesis model by suppressing epidermal proliferation.
January 2013, American journal of translational research,
Adam Glick, and Andrew Ryscavage, and Rolando Perez-Lorenzo, and Henry Hennings, and Stuart Yuspa, and Nadine Darwiche
Biologically motivated two-stage model for cancer risk assessment.
October 1988, Toxicology letters,
Adam Glick, and Andrew Ryscavage, and Rolando Perez-Lorenzo, and Henry Hennings, and Stuart Yuspa, and Nadine Darwiche
A stochastic two-stage model for cancer risk assessment. I. The hazard function and the probability of tumor.
September 1988, Risk analysis : an official publication of the Society for Risk Analysis,
Adam Glick, and Andrew Ryscavage, and Rolando Perez-Lorenzo, and Henry Hennings, and Stuart Yuspa, and Nadine Darwiche
Naringenin Suppresses Chemically Induced Skin Cancer in Two-Stage Skin Carcinogenesis Mouse Model.
January 2020, Nutrition and cancer,
Adam Glick, and Andrew Ryscavage, and Rolando Perez-Lorenzo, and Henry Hennings, and Stuart Yuspa, and Nadine Darwiche
Evidence for a non-stochastic two-field hypothesis for persistent skin cancer risk.
November 2020, Scientific reports,
Adam Glick, and Andrew Ryscavage, and Rolando Perez-Lorenzo, and Henry Hennings, and Stuart Yuspa, and Nadine Darwiche
Evidence for a two-stage model of microbial infection.
June 1968, The Journal of hygiene,
Adam Glick, and Andrew Ryscavage, and Rolando Perez-Lorenzo, and Henry Hennings, and Stuart Yuspa, and Nadine Darwiche
A two-stage carcinogenesis model for risk assessment.
December 1989, Cell biology and toxicology,
Adam Glick, and Andrew Ryscavage, and Rolando Perez-Lorenzo, and Henry Hennings, and Stuart Yuspa, and Nadine Darwiche
[Tumor risk consultation for predisposed women from high risk cancer families].
April 1998, Praxis,
Adam Glick, and Andrew Ryscavage, and Rolando Perez-Lorenzo, and Henry Hennings, and Stuart Yuspa, and Nadine Darwiche
The exact formula for tumor incidence in the two-stage model.
December 1994, Risk analysis : an official publication of the Society for Risk Analysis,
Adam Glick, and Andrew Ryscavage, and Rolando Perez-Lorenzo, and Henry Hennings, and Stuart Yuspa, and Nadine Darwiche
Diet and anticarcinogenesis in the mouse skin two-stage model.
May 1983, Cancer research,
Copied contents to your clipboard!